POLIVY FDA approval date

The FDA approved POLIVY on 10 Jun 2019.

FDA approval date
10 Jun 2019

Drug identity has not yet been verified against registry records

Also recorded as POLATUZUMAB VEDOTIN-PIIQ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-06-10DayPOLIVYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761121", "applicant_as_listed_by_fda": "GENENTECH", "brand_names": ["POLIVY"], "active_ingredients": ["POLATUZUMAB VEDOTIN-PIIQ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190610", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026